The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: Implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma

Molecular and Cellular Probes

Volumn 12, Issue 6, 1998, Pages 421-425

  Lucotte, G ^a   Mercier, G ^b   Burckel, A ^b  

^a HÔPITAL MAISON BLANCHE   (France)

^b European Laboratory of Screening   (France)

Author keywords

Messenger RNA (mRNA); Metastases; Prostate cancer; Prostate specific membrane antigen (PSM); Reverse transcriptase polymerase chain reaction (RT PCR)

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0032405555     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.1998.0201     Document Type: Article

References (12)

1. Moreno J. G., Croce C. M., Fisher R. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Research. 52:1992;6110-6112.
2. Deguchi, T., Doi T., Ehara, H. Detection of micrometastasis prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Research. 53:1993;5350-5354.
3. Katz A. E., de Vries G. M., Begg M. D. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer. 75:1995;1642-1648.
4. Ghossein R. A., Scher H. I., Gerald W. L. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. Journal of Clinical Oncology. 13:1995;1195-1200.
5. Olsson C. A., de Vries G. M., Benson M. C. The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. British Journal of Urology. 77:1996;411-417.
6. Israeli R. S., Miller W. H., Su S. L. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assay. Cancer Research. 54:1994;6306-6310.
7. Israeli R. S., Powell C. T., Fair W. R., Heston S. D. W. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Research. 53:1993;227-230.
8. Israeli R. S., Powell C. T., Corr J. G., Fair W. R., Heston W. D. W. Expression of the prostate-specific membrane antigen. Cancer Research. 54:1994;1807-1811.
9. Loric S., Dumas F., Eschwege P. Enhanced detection of haematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clinical Chemistry. 41:1995;1698-1704.
10. Horoszewicz J. S., Leong S. S., Kawinski E. LNCaP model of human prostatic carcinoma. Cancer Research. 43:1983;1809-1818.
11. Diamandis E. P., Yu H. Prostate cancer, prostate-specific antigen, and the polymerase chain reaction (Editorial). Clinical Chemistry. 41:1995;177-179.
12. Gala J. L., Heusterspreute M., Loric S. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of haematogeneous prostate cells and standardization. Clinical Chemistry. 44:1998;472-481.